Tag: Vulvar Lichen Sclerosus
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
Featured Article
How a small pet food manufacturer supports a 5x increase in production capacity
For Advanced Pet Care of Australia, scaling into one of Australia’s top pet food manufacturers required more than new production capacity – it required better systems.
